Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

RGBP Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the Regen Biopharma Inc. (OTCMKT:RGBP) seasonal charts above shows that a Buy Date of July 29 and a Sell Date of October 18 has resulted in a geometric average return of 35.28% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 92.61% per year.

Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. It also focuses on mRNA and small molecule therapies for treating cancer and autoimmune disorders. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.

To download RGBP seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: RGBP